Prevention of osteoporosis in breast cancer survivors

Trial Profile

Prevention of osteoporosis in breast cancer survivors

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Risedronic acid (Primary) ; Calcium; Vitamin D analogues
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jan 2010 Actual patient number (249) added as reported by ClinicalTrials.gov.
    • 20 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top